Dr. Nickles Fader is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
10753 Falls Road
Pavilion II Suite 245
Lutherville, MD 21093Phone+1 443-997-0400Fax+1 410-367-3312
Summary
- I am a board certified obstetrician gynecologist and board certified gynecologic oncologist who specializes in radical cytoreductive surgery and minimally invasive surgery to treat gynecologic cancer. I am also a clinical trialist and specialize in rare tumor of the uterus and ovary.
Education & Training
- UPMC Medical EducationResidency, Obstetrics and Gynecology, 2002 - 2006
- Virginia Commonwealth University School of MedicineClass of 2002
- Cleveland Clinic FoundationFellowship, Gynecologic Oncology
Certifications & Licensure
- MD State Medical License 2009 - 2025
- OH State Medical License 2004 - 2009
- PA State Medical License 2002 - 2006
- American Board of Obstetrics and Gynecology Obstetrics & Gynecology
- American Board of Obstetrics and Gynecology Gynecologic Oncology
Awards, Honors, & Recognition
- Chair, Oncology Group American Association of Gynecologic Laparscopy, 2014-2015
- Member, Rare Gynecologic Tumor Clinical Trials Group NRG/Gynecologic Oncology Group, 2013-2015
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2013-2014
Publications & Presentations
PubMed
- 39 citationsChemosensitivity testing with ChemoFx and overall survival in primary ovarian cancerThomas J. Herzog, Thomas C. Krivak, Amanda N. Fader, Robert L. Coleman
American Journal of Obstetrics and Gynecology. 2010-07-01 - 127 citationsRandomized Phase II Trial of Carboplatin-Paclitaxel Compared with Carboplatin-Paclitaxel-Trastuzumab in Advanced (Stage III-IV) or Recurrent Uterine Serous Carcinomas ...Amanda N. Fader, Dana M. Roque, Eric R. Siegel, Natalia Buza, Pei Hui
Clinical Cancer Research. 2020-08-01 - 172 citationsPembrolizumab plus Chemotherapy in Advanced Endometrial Cancer.Ramez N Eskander, Michael W Sill, Lindsey Beffa, Richard G Moore, Joanie M Hope
The New England Journal of Medicine. 2023-06-08
Professional Memberships
- Member
- Member
- Member
- Member
Other Languages
- Spanish
External Links
- Johns Hopkins Physicianshttp://www.hopkinsmedicine.org/amanda-nickles-fader
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: